Clinical Trial Update: Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG [Phase 4]

View source ↗

Summary

Phase 4 study evaluating safety, tolerability, and pharmacokinetics of tecovirimat (TPOXX) in adults weighing more than 120 kg with smallpox. The study is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• TPOXX (tecovirimat monohydrate)

Snippet

Sponsor: SIGA Technologies | Conditions: Smallpox | Phase 4 | Status: COMPLETED | Results posted: 2024-09-19